Role of Acid Sphingomyelinase-Induced Signaling in Melanoma Cells for Hematogenous Tumor Metastasis

Autor: Matthias Soddemann, Nadine Beckmann, Katrin Anne Becker, Aaron P. Seitz, Alexander Carpinteiro, Iris Helfrich, Erich Gulbins, Barbara Wilker, Bärbel Edelmann, Gabriele Hessler
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Physiology
Melanoma
Experimental

Medizin
p38 Mitogen-Activated Protein Kinases
p38 kinase
lcsh:Physiology
Metastasis
Ceramide
Mice
0302 clinical medicine
Medicine
lcsh:QD415-436
Neoplasm Metastasis
Phosphorylation
Extracellular Signal-Regulated MAP Kinases
Mice
Knockout

biology
lcsh:QP1-981
Integrin beta1
Melanoma
Sphingomyelin Phosphodiesterase
030220 oncology & carcinogenesis
Signal transduction
Acid sphingomyelinase
Signal Transduction
medicine.drug
Blood Platelets
Cell signaling
Integrin
lcsh:Biochemistry
03 medical and health sciences
Cell Line
Tumor

Cell Adhesion
Animals
Humans
Transplantation
Homologous

Platelet activation
Cell adhesion
Protein Kinase Inhibitors
Sphingolipids
Phospholipase C gamma
business.industry
medicine.disease
Signaling
Mice
Inbred C57BL

Cytoskeletal Proteins
030104 developmental biology
Immunology
Cancer research
biology.protein
business
Tumor metastasis
Zdroj: Cellular Physiology and Biochemistry, Vol 38, Iss 1, Pp 1-14 (2016)
Popis: Background: Hematogenous metastasis of malignant tumor cells is a multistep process that requires release of tumor cells from the local tumor mass, interaction of the tumor cells with platelets in the blood, and adhesion of either the activated tumor cells or the complexes of platelets and tumor cells to the endothelial cells of the target organ. We have previously shown that the interaction of melanoma cells with platelets results in the release of acid sphingomyelinase (Asm) from activated platelets. Secreted platelet-derived Asm acts on malignant tumor cells to cluster and activate integrins; such clustering and activation are necessary for tumor cell adhesion to endothelial cells and for metastasis. Methods: We examined the response of tumor cells to treatment with extracellular sphingomyelinase or co-incubation with wild-type and Asm-deficient platelets. We determined the phosphorylation and activation of several intracellular signaling molecules, in particular p38 kinase (p38K), phospholipase Cγ (PLCγ), ezrin, and extracellular signal-regulated kinases. Results: Incubation of B16F10 melanoma cells with Asm activates p38 MAP kinase (p38K), phospholipase Cγ (PLCγ), ezrin, and extracellular signal-regulated kinases. Co-incubation of B16F10 melanoma cells with wild-type or Asm-deficient platelets showed that the phosphorylation/activation of p38K is dependent on Asm. Pharmacological blockade of p38K prevents activation of β1 integrin and adhesion in vitro. Most importantly, inhibition of p38K activity in B16F10 melanoma cells prevents tumor cell adhesion and metastasis to the lung in vivo, a finding indicating the importance of p38K for metastasis. Conclusions: Asm, secreted from activated platelets after tumor cell-platelet contact, induces p38K phosphorylation in tumor cells. This in turn stimulates β1 integrin activation that is necessary for adhesion and subsequent metastasis of tumor cells. Thus, inhibition of p38K might be a novel target to prevent tumor metastasis.
Databáze: OpenAIRE